4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000794
Director sold 34,141 shares at an average $19.06 ($650,693)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-16 | Sale : show line 1 in the form | −20,548 | $19.27 | $395,960 | 2,096,883 | I |
| 2017-08-17 | Sale : show line 2 in the form | −13,593 | $18.74 | $254,733 | 2,083,290 | I |
| Open-market sales · 34,141 sh · avg $19.06 · $650,693 | ||||||
Loading xslF345X03/vonemster_fm4aug162017.xml…